Expression and prognostic role of RhoA GTPases in hepatocellular carcinoma

[1]  I. Ng,et al.  Deleted in liver cancer 2 (DLC2) suppresses cell transformation by means of inhibition of RhoA activity. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[2]  Kyoko Arai,et al.  Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[3]  I. Ng,et al.  Deleted in Liver Cancer (DLC) 2 Encodes a RhoGAP Protein with Growth Suppressor Function and Is Underexpressed in Hepatocellular Carcinoma* , 2003, The Journal of Biological Chemistry.

[4]  Y. Matsuzawa,et al.  Hepatocellular Carcinoma (hcc) Causes Death in Patients with Cirrhosis and Is One of the Most Prevalent Malignant Tumours Effect of Pravastatin on Survival in Patients with Advanced Hepatocellular Carcinoma. a Randomized Controlled Trial , 2022 .

[5]  S. Hirohashi,et al.  Inhibition of intrahepatic metastasis of human hepatocellular carcinoma by Rho‐associated protein kinase inhibitor Y‐27632 , 2001, Hepatology.

[6]  S. Hirohashi,et al.  Cell motility mediated by rho and rho‐associated protein kinase plays a critical role in intrahepatic metastasis of human hepatocellular carcinoma , 1999, Hepatology.

[7]  B. Kaina,et al.  Rho GTPases are over‐expressed in human tumors , 1999, International journal of cancer.

[8]  K. Itoh,et al.  Overexpression of small GTP-binding protein RhoA promotes invasion of tumor cells. , 1999, Cancer research.

[9]  I. Dixon,et al.  Elevation of expression of Smads 2, 3, and 4, decorin and TGF-beta in the chronic phase of myocardial infarct scar healing. , 1999, Journal of molecular and cellular cardiology.

[10]  W. Kiosses,et al.  Regulation of the small GTP‐binding protein Rho by cell adhesion and the cytoskeleton , 1999, The EMBO journal.

[11]  Shuh Narumiya,et al.  An essential part for Rho–associated kinase in the transcellular invasion of tumor cells , 1999, Nature Medicine.

[12]  F. Matsumura,et al.  Small GTP-binding Protein Rho Stimulates the Actomyosin System, Leading to Invasion of Tumor Cells* , 1998, The Journal of Biological Chemistry.

[13]  H. Kotani,et al.  Regulation of Cell–Cell Adhesion by Rac and Rho Small G Proteins in MDCK Cells , 1997, The Journal of cell biology.

[14]  Shuh Narumiya,et al.  Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension , 1997, Nature.

[15]  H. Toyoda,et al.  Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma , 1997, Hepatology.

[16]  A. Hall,et al.  Rho: a connection between membrane receptor signalling and the cytoskeleton. , 1996, Trends in cell biology.

[17]  S. Kawasaki,et al.  Surgery for small liver cancers. , 1993, Seminars in surgical oncology.

[18]  S. Y. Cajal,et al.  Tumorigenic activity of rho genes from Aplysia californica. , 1993, Oncogene.

[19]  C J Marshall,et al.  Post-translational modifications of p21rho proteins. , 1992, The Journal of biological chemistry.

[20]  R. Stancou,et al.  ADP-ribosylation of the ras-related, GTP-binding protein RhoA inhibits lymphocyte-mediated cytotoxicity. , 1992, The Journal of biological chemistry.

[21]  Frank McCormick,et al.  The GTPase superfamily: a conserved switch for diverse cell functions , 1990, Nature.

[22]  R. Weinberg,et al.  Characterization and expression of the human rhoH12 gene product , 1989, Molecular and cellular biology.

[23]  S. Sebti,et al.  Inhibition of Ras prenylation: a novel approach to cancer chemotherapy. , 1997, Pharmacology & therapeutics.

[24]  P. Casey,et al.  Protein prenylation: molecular mechanisms and functional consequences. , 1996, Annual review of biochemistry.

[25]  K. Chayama,et al.  Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma , 1993, Cancer.

[26]  S. Narumiya,et al.  rho gene products, botulinum C3 exoenzyme and cell adhesion. , 1993, Cellular signalling.